Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 551 - 600 out of 7,930

Document Document Title
WO/2006/084716A1
The present invention relates to newly identified genes that encode proteins that are involved in the synthesis of L-ascorbic acid (hereinafter also referred to as Vitamin C). The invention also features polynucleotides comprising the fu...  
WO/2006/084722A2
The present invention relates to newly identified genes that encode proteins that are involved in the synthesis of L-ascorbic acid (hereinafter also referred to as Vitamin C). The invention also features polynucleotides comprising the fu...  
WO/2006/084727A1
The present invention relates to newly identified genes that encode proteins that are involved in the synthesis of L-ascorbic acid (hereinafter also referred to as Vitamin C). The invention also features polynucleotides comprising the fu...  
WO/2006/085535A1
Biopterin is a useful compound to be used in a pharmaceutical product or a functional food. Conventionally, the presence of sepiapterin reductase (SPR) involved in the biosynthesis of biopterin has not been confirmed in microorganisms wi...  
WO/2006/084734A1
The present invention relates to newly identified genes that encode proteins that are involved in the synthesis of L-ascorbic acid (hereinafter also referred to as Vitamin C). The invention also features polynucleotides comprising the fu...  
WO/2006/084706A2
The present invention relates to newly identified genes that encode proteins that are involved in the synthesis of L-ascorbic acid (hereinafter also referred to as Vitamin C). The invention also features polynucleotides comprising the fu...  
WO/2006/084733A1
The present invention relates to newly identified genes that encode proteins that are involved in the synthesis of L-ascorbic acid (hereinafter also referred to as Vitamin C). The invention also features polynucleotides comprising the fu...  
WO2006012277A3
biocatalytic process for preparing enantiomerically enriched pramipexole and pramipexole precursors are disclosed.  
WO/2006/080328A1
A substance having an antimicrobial activity against heat-resistant sporeforming bacteria, which can be used for improving storage duration of drink or processed food or preventing bacteria for cosmetic is provided. The invention is dire...  
WO/2006/080409A1
Disclosed are a novel hydantoin racemase and a process for producing an optically active N-carbamylamino acid or an optically active amino acid using the hydantoin racemase. A novel hydantoin racemase isolated and purified from Bacillus ...  
WO2005017486A3
This invention demonstrates the feasibility of producing an easy to use, marketable global test in the arena of clinical haemostasis testing that is sensitive to antithrombotic drugs, bleeding disorders and thrombotic pathologies. Use of...  
WO2006061425A3
The present invention describes the transformation of a microorganism that does not naturally produce a beta-lactam compound with polynucleotides involved in the biosynthesis of beta-lactam compounds and the use of such transformed micro...  
WO/2006/078368A1
A process of the large-scale fermentation of a highly productive ansamitocin-producing strains. A method for isolating crude ansamitocins. A method for purifying ansamitocins.  
WO/2006/075013A1
The present invention relates to nucleic acid sequences and proteins derivable therefrom that have been identified in Sorangium cellulosum, which proteins are catalytically active or participate in the biosynthetic pathway of disorazoles...  
WO2005047509A3
The present invention relates to Mycobacterium ulceran virulence plasmid, pMUM001 and particularly to a cluster of genes carried by this plasmid that encode polyketide synthases (PKSs) and polyketide-modifying enzymes necessary and suffi...  
WO/2006/075395A1
Penicillium citrinum FKI-1938 (FERM ABP-10165) that belongs to Penicillium citrinum and has an ability of producing FKI-1938A substance is cultured in a medium to accumulate FKI-1938A substance in the culture, and FKI-1938A substance tha...  
WO2006015727A3
The invention relates to a method for producing, in essence, enantiomer-pure 3-hydroxycarboxylic acids or esters of general formula (III) by reacting racemic oxetan-2-ones of general formula (I) with compounds R3-OH of general formula (I...  
WO2006046130A3
The invention relates to a process for the preparation of pure pravastatin or a salt thereof using adsorption matrices. The invention also relates to pharmaceutical compositions that include the pure pravastatin and the use of the compos...  
WO/2006/070775A1
A process for the production of D-firefly luciferin or luminescent derivatives thereof, characterized by reacting an L-firefly luciferin raw material containing at least one member selected from the group consisting of (1) esters of L-fi...  
WO/2006/067535A1
Abstract The present invention relates to a novel source of microorganism for production of Camptothecin and related camptothecinoids. The invention also discloses its isolation, screening for Camptothecin production, growth, fermentatio...  
WO2005116061A3
The invention relates to DNA sequences coding for polypeptides which, in turn, participate in the enzymatic biosynthesis of polyketide compounds, and to amino acid sequences of said polypeptides. The invention also relates to the use of ...  
WO2005086907A3
Domains of ambruticin polyketide synthase and modificationenzymes and polynucleotides encoding them are provided. Methods to prepare ambruticin in pharmaceutically useful quantities are described, as are methods to prepare ambruticin ana...  
WO/2006/065767A3
Improved catalytic enzyme preparations are provided which effectively catalyze reactions carried out inorganic solvents. The preparations comprise nanoscale solid support particles (e.g., fumed silica or alumina) having enzyme molecules ...  
WO2006015716A3
The invention relates to a method for producing chiral, non-racemic, cis-configured cyclohexanols or cyclohexanol derivatives of formulae (la) and (Ib) wherein the radicals have the designations cited in the description, by means of enzy...  
WO2005121327A3
A polyketide synthase complex composed of polyketide synthase with 15 total modules, a non-ribosomal peptide synthetase with I module, and a cytochrome P450 hydroxylase is described. Also provided are novel Streptomyces species and metho...  
WO/2006/066147A3
Antifungal compounds represented by formula I where R1, R2, R3 and R4 are as defined herein. Isolated or purified naturally occurring 20,21-dihydro ambruticin compounds. The invention also provides Sorangium cellulosum ambM, ambO, ambP, ...  
WO/2006/063055A3
Disclosed are detoxifying enzyme conjugates, including conjugates of variants of such detoxifying enzymes. The detoxifying enzymes are preferably chlolinesterases, and more preferably , butyrylcholinesterase. Also disclosed are methods o...  
WO/2006/061425A2
The present invention describes the transformation of a microorganism that does not naturally produce a beta-lactam compound with polynucleotides involved in the biosynthesis of beta-lactam compounds and the use of such transformed micro...  
WO/2006/059400A1
A microorganism (Penicillium sp. FKI-2140, FERM ABP-10165), which belongs to fungi and is capable of producing antibiotics FKI-2140 (FKI-2140A1 or A2, and/or FKI-2140B, and/or FKI-2140C, and/or FKI-2140D, and/or FKI-2140E, and/or FKI-214...  
WO2006032232A3
The invention relates to novel genes from lysolipin-producing microorganisms, to novel gene clusters formed from novel and/or known genes of these microorganisms, to expression products of these genes, to a transformation vehicle contain...  
WO/2006/060803A3
Disclosed is a method for the synthesis of sterically hindered polymeric antioxidants based on phenol type antioxidant monomers. The method includes mono-deacetylating, polymerizing and deacetylating an aryl monomer represented by the fo...  
WO/2006/057341A1
After culturing for a definite period of time, a mutant of wild type Escherichia coli, which has a chromosomal DNA shorter by 470 kbp or more than the chromosomal DNA of the wild type, shows a larger cell count than the wild type. Theref...  
WO2005019426A3
Domains of fostriecin polyketide synthase and modification enzymes and polynucleotides encoding them are provided. Methods to prepare fostriecin in pharmaceutically useful quantities are described, as are methods to prepare fostriecin an...  
WO/2006/054500A1
[PROBLEMS] To provide a methylated catechin synthase gene by which methylated catechin having a high antiallergic activity can be efficiently biosynthesized. [MEANS FOR SOLVING PROBLEMS] A gene encoding an enzyme capable of biosynthesizi...  
WO/2006/055528A2
The present disclosure provides enzymatic methods for generating stereoisomerically pure products by resolving a racemic mixture of N-protected β-lactams with a lipase from Candida antarctica with high stereospecificity. The presence of...  
WO/2006/047891A1
This invention relates to novel biologically active polycyclic aromatics produced by cultivation of Micromonospora echinospora ssp. challisensis NRRL 12255. The invention also relates to their pharmaceutically acceptable salts, prodrugs ...  
WO/2006/048551A1
The inventive method for stereoselectively preparing a (R) or (S) gamma-lactone consists in microbially biosynthesising gamma-lactone, wherein said biosynthesis is carried out from a substrate selected from C5 to C20 fatty acids with the...  
WO/2006/048947A1
Macrophage foaming inhibitor FKI-1840, and a process for producing the same, comprising incubating a microbe belonging to the genus Phoma which is capable of producing the substance FKI-1840 (Phoma sp. FKI-1840, FERM ABP-10150) in a cult...  
WO/2006/048550A1
The invention relates to a gamma-undecenolactone of formula (i), wherein a lactonic cycle can carry an unsaturation between carbon N°2 and carbon N°3 and is preferably saturated, RI is a possibly substituted C7 alkenyl or alkynyl group...  
WO/2006/046130A2
The invention relates to a process for the preparation of pure pravastatin or a salt thereof using adsorption matrices. The invention also relates to pharmaceutical compositions that include the pure pravastatin and the use of the compos...  
WO2006031661A3
Although macrolide compounds are insoluble in water, surprisingly high part of the product was found in the liquid phase of the fermentation broth. Therefore, processing the entire fermentation broth, i.e. the suspension obtained by cult...  
WO/2006/046314A1
Microbe (Penicillium citrinum FKI-1938, FERM ABP-10149) belonging to the genus Penicillium citrinum and capable of producing substance FKI-1938A and/or substance FKI-1938B and/or substance FKI-1938B’ and/or substance FKI-1938C is incub...  
WO/2006/046152A2
The invention provides a method for the heterologous expression of a secondary metabolite encoded by a biosynthetic pathway. Also provided is a method for introducing a large sized DNA molecule into the chromosome of a heterologous host ...  
WO2003066871A3
Isolated nucleic acid and amino acid sequences for phenylalanine aminomutase enzyme and methods for purifying this enzyme are provided. Methods for altering biosynthesis of compounds in plant cell cultures are also provided. In particula...  
WO/2006/038218A1
The present invention discloses the manufacture of MPA by fermentation under optimal fermentation parameters using a new strain of Penicillium arenicola.  
WO2005100569A3
The invention provides yeast strains, and polypeptides encoded by genes of such yeast strains, that have enantiospecific styrene epoxide hydrolase activity. The invention also features nucleic acid molecules encoding such polypeptides, v...  
WO/2006/034567A1
This invention relates to methods of inhibiting growth and/or proliferation of a neoplastic cell, and methods of treating neoplasms using the farnesylated dibenzodiazepinone compound of Formula I. The invention includes pharmaceutical co...  
WO2005108590A3
The invention relates to a method for producing the optically active alkanols of formula (I), wherein n is an integer of from 0 to 5; Cyc represents an optionally substituted, mononuclear or polynuclear, saturated or unsaturated, carbocy...  
WO2006015811A3
The invention relates to a dihydrocoumarin that has been technically produced by the biotransformation of coumarin and to associated production variants that are carried out with the aid of isolated enzymes and/or microorganisms. Pure co...  
WO/2006/035770A1
[PROBLEMS] To provide a process for synthesizing natural compound derivatives useful in random high-throughput screening (HTS), the search for drugs or agricultural chemicals, the search for lead compounds of drugs or agricultural chemic...  

Matches 551 - 600 out of 7,930